Advanced search
Publication Cover
Expert Review of Obstetrics & Gynecology Volume 7, 2012 - Issue 6
Journal homepage
7
Views
11
CrossRef citations to date
0
Altmetric
Review

Effects of menopause on autoimmune diseases

Miranda A Farage The Procter and Gamble Company, Winton Hill Business Center, Cincinnati, OH, USA; The Procter and Gamble Company, Winton Hill Business Center, Cincinnati, OH, USA. [email protected]
,
Kenneth W Miller The Procter and Gamble Company, Winton Hill Business Center, Cincinnati, OH, USA; The Procter and Gamble Company, Winton Hill Business Center, Cincinnati, OH, USA
&
Howard I Maibach University of California, San Francisco, CA, USA; University of California, San Francisco, CA, USA
Pages 557-571 | Published online: 10 Jan 2014

References

  • Bulati M, Pellicanò M, Vasto S, Colonna-Romano G. Understanding ageing: biomedical and bioengineering approaches, the immunologic view. Immun. Ageing 5, 9 (2008).
  • Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science 296(5570), 1029–1031 (2002).
  • Kochanek KD, Xu JQ, Murphy SLEA. Deaths: Preliminary Data for 2009. National Vital Statistics Reports; vol 59 no 4. National Center for Health Statistics, MD, USA (2011).
  • Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G. Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 23, 64–74 (2008).
  • Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology 120(4), 435–446 (2007).
  • Tobias L. A Briefing Report on Autoimmune Diseases and AARDA: Past, Present, and Future. American Autoimmune Related Diseases Association (AARDA), MI, USA (2010).
  • Ramos-Casals M, García-Carrasco M, Brito MP, López-Soto A, Font J. Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly. Lupus 12(5), 341–355 (2003).
  • Mund E. Gender differences in immunity over human lifespan. Eur. Respir. Mon. 25, 26–38 (2003).
  • Farage MA, Miller KW, Elsner P, Maibach HI. Functional and physiological characteristics of the aging skin. Aging Clin. Exp. Res. 20(3), 195–200 (2008).
  • Gameiro CM, Romão F, Castelo-Branco C. Menopause and aging: changes in the immune system – a review. Maturitas 67(4), 316–320 (2010).
  • Ku LT, Gercel-Taylor C, Nakajima ST, Taylor DD. Alterations of T cell activation signalling and cytokine production by postmenopausal estrogen levels. Immun. Ageing 6, 1 (2009).
  • Mello Coelho V, Bunbury A, Rangel LB et al. Fat-storing multilocular cells expressing CCR5 increase in the thymus with advancing age: potential role for CCR5 ligands on the differentiation and migration of preadipocytes. Int. J. Med. Sci. 7(1), 1–14 (2009).
  • Crétel E, Veen I, Pierres A et al. [Immune profile of elderly patients admitted in a geriatric short care unit]. Rev. Med. Interne 32(5), 275–282 (2011).
  • Utsuyama M, Hirokawa K, Kurashima C et al. Differential age-change in the numbers of CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech. Ageing Dev. 63(1), 57–68 (1992).
  • Stacy S, Krolick KA, Infante AJ, Kraig E. Immunological memory and late onset autoimmunity. Mech. Ageing Dev. 123(8), 975–985 (2002).
  • Aspinall R, Andrew D. Thymic involution in aging. J. Clin. Immunol. 20(4), 250–256 (2000).
  • Luz C, Collaziol D, Preissler T, da Cruz IM, Glock L, Bauer ME. Healthy aging is associated with unaltered production of immunoreactive growth hormone but impaired neuroimmunomodulation. Neuroimmunomodulation 13(3), 160–169 (2006).
  • Kurashima C, Utsuyama M. Age-related changes of cytokine production by murine helper T cell subpopulations. Pathobiology 65(3), 155–162 (1997).
  • Listì F, Candore G, Modica MA et al. A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann. NY Acad. Sci. 1089, 487–495 (2006).
  • Gangemi S, Basile G, Monti D et al. Age-related modifications in circulating IL-15 levels in humans. Mediators Inflamm. 2005(4), 245–247 (2005).
  • Solana R, Pawelec G, Tarazona R. Aging and innate immunity. Immunity 24(5), 491–494 (2006).
  • Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 5(3), 243–251 (2005).
  • Nalbandian G, Kovats S. Estrogen, immunity and autoimmune disease. Curr. Med. Chem. Immun. Endo. Metab. Agents 5, 85–91 (2005).
  • Dolomie-Fagour L, Gatta B, Nguyen TD, Corcuff JB. Bioavailable estradiol in man: relationship with age and testosterone. Clin. Chim. Acta 398(1–2), 145–147 (2008).
  • Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male 5(2), 98–102 (2002).
  • Pietschmann P, Gollob E, Brosch S et al. The effect of age and gender on cytokine production by human peripheral blood mononuclear cells and markers of bone metabolism. Exp. Gerontol. 38(10), 1119–1127 (2003).
  • Ongrádi J, Kövesdi V. Factors that may impact on immunosenescence: an appraisal. Immun. Ageing 7, 7 (2010).
  • Papenfuss TL, Whitacre CC. Sex hormones, pregnancy, and imuune function. In: Hormones, Brain, and Behavior. Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT (Eds). Academic Press, CA, USA, 367–376 (2009).
  • Ahmed SA, Hissong BD, Verthelyi D, Donner K, Becker K, Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ. Health Perspect. 107(Suppl. 5), 681–686 (1999).
  • Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am. J. Pathol. 121(3), 531–551 (1985).
  • Gameiro C, Romao F. Changes in the immune system during menopause and aging. Front. Biosci. (Elite Ed). 2, 1299–1303 (2010).
  • Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am. J. Pathol. 173(3), 600–609 (2008).
  • Beagley KW, Gockel CM. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol. Med. Microbiol. 38(1), 13–22 (2003).
  • Marzi M, Vigano A, Trabattoni D et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 106(1), 127–133 (1996).
  • Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J. Clin. Invest. 109(12), 1625–1633 (2002).
  • González DA, Díaz BB, Rodríguez Pérez MDC, Hernández AG, Chico BND, de León AC. Sex hormones and autoimmunity. Immunol. Lett. 133(1), 6–13 (2010).
  • Shapira Y, Agmon-Levin N, Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J. Autoimmun. 34(3), J168–J177 (2010).
  • Hemminki K, Li X, Sundquist K, Sundquist J. Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum. 60(9), 2845–2847 (2009).
  • Olsen NJ, Kovacs WJ. Effects of androgens on T and B lymphocyte development. Immunol. Res. 23(2–3), 281–288 (2001).
  • Selmi C, Brunetta E, Raimondo MG, Meroni PL. The X chromosome and the sex ratio of autoimmunity. Autoimmun. Rev. 11(6–7), A531–A537 (2012).
  • Buyon JP. The effects of pregnancy on autoimmune diseases. J. Leukoc. Biol. 63(3), 281–287 (1998).
  • Sánchez-Guerrero J, Villegas A, Mendoza-Fuentes A, Romero-Díaz J, Moreno-Coutiño G, Cravioto MC. Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus. Am. J. Med. 111(6), 464–468 (2001).
  • Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. Immunol. Today 10(4), 123–126 (1989).
  • Tiller T, Tsuiji M, Yurasov S, Velinzon K, Nussenzweig MC, Wardemann H. Autoreactivity in human IgG+ memory B cells. Immunity 26(2), 205–213 (2007).
  • Béland K, Lapierre P, Alvarez F. Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. World J. Gastroenterol. 15(9), 1025–1034 (2009).
  • Njemini R, Meyers I, Demanet C, Smitz J, Sosso M, Mets T. The prevalence of autoantibodies in an elderly sub-Saharan African population. Clin. Exp. Immunol. 127(1), 99–106 (2002).
  • Hasler P, Zouali M. Immune receptor signaling, aging, and autoimmunity. Cell. Immunol. 233(2), 102–108 (2005).
  • Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun. Rev. 3(5), 401–406 (2004).
  • Fülöp T Jr, Larbi A, Dupuis G, Pawelec G. Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing – a biochemical paradigm for the ageing immune system. Arthritis Res. Ther. 5(6), 290–302 (2003).
  • Cai Y, Zhou J, Webb DC. Estrogen stimulates Th2 cytokine production and regulates the compartmentalisation of eosinophils during allergen challenge in a mouse model of asthma. Int. Arch. Allergy Immunol. 158(3), 252–260 (2012).
  • Tai P, Wang J, Jin H et al. Induction of regulatory T cells by physiological level estrogen. J. Cell. Physiol. 214(2), 456–464 (2008).
  • Linterman MA, Rigby RJ, Wong RK et al. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206(3), 561–576 (2009).
  • Bodey B, Siegel SE, Kaiser HE. Involution of the mammalian thymus and its role in the aging process. In: Immunological Aspects of Neoplasia – The Role of the Thymus. Kluwer Academic Publishers, Dordrecht, The Netherlands, 147–166 (2004).
  • Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. Involution of the mammalian thymus, one of the leading regulators of aging. In Vivo 11(5), 421–440 (1997).
  • Porter VR, Greendale GA, Schocken M, Zhu X, Effros RB. Immune effects of hormone replacement therapy in post-menopausal women. Exp. Gerontol. 36(2), 311–326 (2001).
  • Grimaldi CM, Michael DJ, Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167(4), 1886–1890 (2001).
  • Giglio T, Imro MA, Filaci G et al. Immune cell circulating subsets are affected by gonadal function. Life Sci. 54(18), 1305–1312 (1994).
  • Kumru S, Godekmerdan A, Yilmaz B. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women. J. Reprod. Immunol. 63(1), 31–38 (2004).
  • Chakravarti B, Abraham GN. Aging and T-cell-mediated immunity. Mech. Ageing Dev. 108(3), 183–206 (1999).
  • Thongngarm T, Jenkins JK, Ndebele K, McMurray RW. Estrogen and progesterone modulate monocyte cell cycle progression and apoptosis. Am. J. Reprod. Immunol. 49(3), 129–138 (2003).
  • Medina KL, Strasser A, Kincade PW. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 95(6), 2059–2067 (2000).
  • Namjou B, Scofield RH, Kelly JA et al. The effects of previous hysterectomy on lupus. Lupus 18(11), 1000–1005 (2009).
  • Vallin H, Blomberg S, Alm GV, Cederblad B, Rönnblom L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-a (IFN-a) production acting on leucocytes resembling immature dendritic cells. Clin. Exp. Immunol. 115(1), 196–202 (1999).
  • Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun. Rev. 6(6), 366–372 (2007).
  • Cutolo M. Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J. Rheumatol. 31(3), 419–421 (2004).
  • Mok CC, Lau CS, Ho CT, Wong RW. Do flares of systemic lupus erythematosus decline after menopause? Scand. J. Rheumatol. 28(6), 357–362 (1999).
  • Abdou NI, Rider V, Greenwell C, Li X, Kimler BF. Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial. J. Rheumatol. 35(5), 797 (2008).
  • Dinesh RK, Hahn BH, Singh RP. PD-1, gender, and autoimmunity. Autoimmun. Rev. 9(8), 583–587 (2010).
  • Minami Y, Sasaki T, Komatsu S et al. Female systemic lupus erythematosus in Miyagi Prefecture, Japan: a case–control study of dietary and reproductive factors. Tohoku J. Exp. Med. 169(3), 245–252 (1993).
  • Minami Y, Sasaki T, Komatsu S et al. Female systemic lupus erythematosus in Miyagi Prefecture, Japan: a case–control study of dietary and reproductive factors. Tohoku J. Exp. Med. 169(3), 245–252 (1993).
  • Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case–control study. Arthritis Rheum. 46(7), 1830–1839 (2002).
  • Font J, Pallarés L, Cervera R et al. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann. Rheum. Dis. 50(10), 702–705 (1991).
  • Ho CT, Mok CC, Lau CS, Wong RW. Late onset systemic lupus erythematosus in southern Chinese. Ann. Rheum. Dis. 57(7), 437–440 (1998).
  • Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore) 83(6), 348–359 (2004).
  • Mok CC, Wong RW, Lau CS. Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum. 42(6), 1274–1280 (1999).
  • Urowitz MB, Ibañez D, Jerome D, Gladman DD. The effect of menopause on disease activity in systemic lupus erythematosus. J. Rheumatol. 33(11), 2192–2198 (2006).
  • Buyon JP, Petri MA, Kim MY et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann. Intern. Med. 142(12 Pt 1), 953–962 (2005).
  • Askanase AD. Estrogen therapy in systemic lupus erythematosus. Treat. Endocrinol. 3(1), 19–26 (2004).
  • González LA, Pons-Estel GJ, Zhang JS et al.; LUMINA Study Group. Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII). Lupus 18(2), 184–186 (2009).
  • Bynoté KK, Hackenberg JM, Korach KS, Lubahn DB, Lane PH, Gould KA. Estrogen receptor-a deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice. Genes Immun. 9(2), 137–152 (2008).
  • Cutolo M, Sulli A, Capellino S et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 13(9), 635–638 (2004).
  • Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179(9), 6352–6358 (2007).
  • Rider V, Jones S, Evans M, Bassiri H, Afsar Z, Abdou NI. Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J. Rheumatol. 28(12), 2644–2649 (2001).
  • Zhang J, Jacobi AM, Wang T, Berlin R, Volpe BT, Diamond B. Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J. Autoimmun. 33(3–4), 270–274 (2009).
  • Weyand CM, Fulbright JW, Goronzy JJ. Immunosenescence, autoimmunity, and rheumatoid arthritis. Exp. Gerontol. 38(8), 833–841 (2003).
  • Olsen NJ, Kovacs WJ. Hormones, pregnancy, and rheumatoid arthritis. J. Gend. Specif. Med. 5(4), 28–37 (2002).
  • Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum. 35(2), 152–155 (1992).
  • Abdou NI, Rider V. Gender differences in autoimmune diseases: immune mechanisms and clincial applications. In: Principles of Gender-Specific Medicine. Lagato M (Ed.). Academic Press, London, UK, 585–591 (2010).
  • Lindstrom TM, Robinson WH. Rheumatoid arthritis: a role for immunosenescence? J. Am. Geriatr. Soc. 58(8), 1565–1575 (2010).
  • Merlino LA, Cerhan JR, Criswell LA, Mikuls TR, Saag KG. Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women. Semin. Arthritis Rheum. 33(2), 72–82 (2003).
  • Pikwer M, Bergström U, Nilsson JÅ, Jacobsson L, Turesson C. Early menopause is an independent predictor of rheumatoid arthritis. Ann. Rheum. Dis. 71(3), 378–381 (2012).
  • Kuiper S, van Gestel AM, Swinkels HL, de Boo TM, da Silva JA, van Riel PL. Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J. Rheumatol. 28(8), 1809–1816 (2001).
  • Doran MF, Crowson CS, O’Fallon WM, Gabriel SE. The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study. J. Rheumatol. 31(2), 207–213 (2004).
  • Holroyd CR, Edwards CJ. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus. Climacteric 12(5), 378–386 (2009).
  • Bhadauria S, Moser DK, Clements PJ et al. Genital tract abnormalities and female sexual function impairment in systemic sclerosis. Am. J. Obstet. Gynecol. 172(2 Pt 1), 580–587 (1995).
  • Scorza R, Caronni M, Bazzi S et al. Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann. NY Acad. Sci. 966, 238–246 (2002).
  • Beretta L, Caronni M, Origgi L, Ponti A, Santaniello A, Scorza R. Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scand. J. Rheumatol. 35(6), 468–471 (2006).
  • Hayashi Y, Arakaki R, Ishimaru N. Apoptosis and estrogen deficiency in primary Sjögren syndrome. Curr. Opin. Rheumatol. 16(5), 522–526 (2004).
  • Ishimaru N, Arakaki R, Watanabe M, Kobayashi M, Miyazaki K, Hayashi Y. Development of autoimmune exocrinopathy resembling Sjögren’s syndrome in estrogen-deficient mice of healthy background. Am. J. Pathol. 163(4), 1481–1490 (2003).
  • Smith R, Studd JW. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J. R. Soc. Med. 85(10), 612–613 (1992).
  • Buchel E, Van Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am. J. Gastroenterol. 97(12), 3160–3165 (2002).
  • Samuel D, Riordan S, Strasser S, Kurtovic J, Singh-Grewel I, Koorey D. Severe autoimmune hepatitis first presenting in the early post partum period. Clin. Gastroenterol. Hepatol. 2(7), 622–624 (2004).
  • Allman D, Miller JP. B cell development and receptor diversity during aging. Curr. Opin. Immunol. 17(5), 463–467 (2005).
  • Huppert FA, Solomou W, O’Connor S, Morgan K, Sussams P, Brayne C. Aging and lymphocyte subpopulations: whole-blood analysis of immune markers in a large population sample of healthy elderly individuals. Exp. Gerontol. 33(6), 593–600 (1998).
  • Franceschi C, Cossarizza A. Introduction: the reshaping of the immune system with age. Int. Rev. Immunol. 12(1), 1–4 (1995).
  • Johnson SA, Cambier JC. Ageing, autoimmunity and arthritis: senescence of the B cell compartment – implications for humoral immunity. Arthritis Res. Ther. 6(4), 131–139 (2004).
  • Frasca D, Riley RL, Blomberg BB. Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans. Semin. Immunol. 17(5), 378–384 (2005).
  • Whisler RL, Liu BQ, Newhouse YG, Walters JD, Breckenridge MB, Grants IS. Signal transduction in human B cells during aging: alterations in stimulus-induced phosphorylations of tyrosine and serine/threonine substrates and in cytosolic calcium responsiveness. Lymphokine Cytokine Res. 10(6), 463–473 (1991).
  • Paganelli R, Quinti I, Fagiolo U et al. Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin. Exp. Immunol. 90(2), 351–354 (1992).
  • Fann M, Chiu WK, Wood WH 3rd, Levine BL, Becker KG, Weng NP. Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging. Immunol. Rev. 205, 190–206 (2005).
  • Mo R, Chen J, Han Y et al. T cell chemokine receptor expression in aging. J. Immunol. 170(2), 895–904 (2003).
  • Weng NP. Aging of the immune system: how much can the adaptive immune system adapt? Immunity 24(5), 495–499 (2006).
  • Tarazona R, De la Rosa O, Alonso C et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech. Ageing Dev. 121(1–3), 77–88 (2000).
  • Ershler WB, Sun WH, Binkley N et al. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res. 12(4), 225–230 (1993).
  • Brüünsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol. Allergy Clin. North Am. 23(1), 15–39 (2003).
  • Niwa Y, Kasama T, Kawai S et al. The effect of aging on cutaneous lipid peroxide levels and superoxide dismutase activity in guinea pigs and patients with burns. Life Sci. 42(4), 351–356 (1988).
  • Tortorella C, Piazzolla G, Spaccavento F, Pece S, Jirillo E, Antonaci S. Spontaneous and Fas-induced apoptotic cell death in aged neutrophils. J. Clin. Immunol. 18(5), 321–329 (1998).
  • Mattila PS, Tarkkanen J. Age-associated changes in the cellular composition of the human adenoid. Scand. J. Immunol. 45(4), 423–427 (1997).
  • Miller RA, Garcia G, Kirk CJ, Witkowski JM. Early activation defects in T lymphocytes from aged mice. Immunol. Rev. 160, 79–90 (1997).
  • Naylor K, Li G, Vallejo AN et al. The influence of age on T cell generation and TCR diversity. J. Immunol. 174(11), 7446–7452 (2005).
  • Quadri RA, Plastre O, Phelouzat MA, Arbogast A, Proust JJ. Age-related tyrosine-specific protein phosphorylation defect in human T lymphocytes activated through CD3, CD4, CD8 or the IL-2 receptor. Mech. Ageing Dev. 88(3), 125–138 (1996).
  • Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat. Immunol. 5(2), 133–139 (2004).
  • Swain S, Clise-Dwyer K, Haynes L. Homeostasis and the age-associated defect of CD4 T cells. Semin. Immunol. 17(5), 370–377 (2005).
  • Vallejo AN, Weyand CM, Goronzy JJ. Functional disruption of the CD28 gene transcriptional initiator in senescent T cells. J. Biol. Chem. 276(4), 2565–2570 (2001).
  • Messaoudi I, Lemaoult J, Guevara-Patino JA, Metzner BM, Nikolich-Zugich J. Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense. J. Exp. Med. 200(10), 1347–1358 (2004).
  • Goronzy JJ, Weyand CM. Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity – catalysts of autoimmunity and chronic inflammation. Arthritis Res. Ther. 5(5), 225–234 (2003).
  • Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl Acad. Sci. USA 100(15), 9090–9095 (2003).
  • Whisler RL, Beiqing L, Chen M. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT. Cell. Immunol. 169(2), 185–195 (1996).
  • Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J. Allergy Clin. Immunol. 103(2 Pt 1), 282–288 (1999).
  • O’Connor MF, Motivala SJ, Valladares EM, Olmstead R, Irwin MR. Sex differences in monocyte expression of IL-6: role of autonomic mechanisms. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293(1), R145–R151 (2007).
  • Lamon-Fava S, Posfai B, Schaefer EJ. Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women. Am. J. Cardiol. 91(2), 252–254 (2003).
  • Miller AP, Feng W, Xing D et al. Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation 110(12), 1664–1669 (2004).
  • Bynoe MS, Grimaldi CM, Diamond B. Estrogen up-regulates BCL-2 and blocks tolerance induction of naive B cells. Proc. Natl Acad. Sci. USA 97(6), 2703–2708 (2000).
  • Srivastava S, Weitzmann MN, Cenci S, Ross FP, Adler S, Pacifici R. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J. Clin. Invest. 104(4), 503–513 (1999).
  • Koh KK, Ahn JY, Jin DK et al. Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 22(9), 1459–1464 (2002).
  • Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM. The hypothalamic–pituitary–gonadal axis: immune function and autoimmunity. J. Endocrinol. 176(3), 293–304 (2003).
  • Ackerman LS. Sex hormones and the genesis of autoimmunity. Arch. Dermatol. 142(3), 371–376 (2006).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.